Our therapeutics are founded on the novel scientific discovery of a pathway, the IGFBP3/TMEM219 axis, found to be involved in stem cell apoptosis in the gut, as well as pancreatic and other tissues.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.